Hitting the (bio)mark part 1: selecting and measuring biomarkers in cardiovascular research

Bo Daelman,Brittany Butts,Quin E Denfeld

DOI: https://doi.org/10.1093/eurjcn/zvae014

2024-02-05

European Journal of Cardiovascular Nursing

Abstract:Abstract Cardiovascular studies, including nursing research, frequently integrate biomarkers for diagnostic, prognostic, monitoring, and therapeutic insights. However, effective utilization of biomarker data demands careful consideration. In the study design phase, researchers must select biomarkers that align with study objectives while considering resources and logistical factors. Additionally, a nuanced understanding of disease pathophysiology and biomarker characteristics is needed. During data collection, suitable experimental conditions and assays need to be defined. Whether researchers opt to manage these steps internally or outsource some, a comprehensive understanding of biomarker selection and experiments remains crucial. In this article, part 1 of 2, we provide an overview of considerations for the design to measurement phases of biomarker studies.

nursing,cardiac & cardiovascular systems

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to select and measure biomarkers in cardiovascular research. Specifically, the paper focuses on the following aspects:

1. **Selection in the research design stage**: When selecting biomarkers, researchers need to consider whether these markers match the research objectives, and also need to consider resource and logistical factors. For example, researchers need to understand the pathophysiology of the disease and the characteristics of biomarkers.

2. **Definition of experimental conditions in the data collection stage**: During the data collection process, appropriate experimental conditions and detection methods need to be defined. This includes determining the time points of sample collection, sample types (such as blood, urine, etc.), sample handling methods (such as centrifugation, aliquoting, etc.), and storage conditions.

3. **Comprehensive understanding of experimental design**: Whether these steps are internally managed or outsourced to other institutions, a comprehensive understanding of biomarker selection and experiments is crucial. This involves considerations of the biological stability, specificity, sensitivity, and predictive value of biomarkers.

4. **Selection of experimental methods**: Select appropriate detection methods (such as enzyme - linked immunosorbent assay (ELISA), liquid chromatography (LC), mass spectrometry (MS), etc.) to ensure accurate measurement of the selected biomarkers, while taking into account cost - effectiveness, operational complexity, and technical requirements.

5. **Execution of the experiment**: When conducting the experiment, attention should be paid to the influence of environmental conditions, instrument calibration, establishment of standard curves, detailed recording of experimental steps, and accurate recording of results to ensure high - quality data output.

In summary, this paper aims to provide a systematic framework for biomarker selection and measurement in cardiovascular research, helping researchers make informed decisions at all stages from research design to data reporting.